Development of Glycoconjugated Porphyrin Derivatives for Photodynamic Therapy
用于光动力治疗的糖基卟啉衍生物的开发
基本信息
- 批准号:13557211
- 负责人:
- 金额:$ 8.64万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.Novel Synthetic Strategy for Glycoconjuated Porphyrin DerivativesIn order to improve the yield of glycoconjugated porphyrin derivatives, especially for meta-substituted tetraphenyl porphyrin, Zn2+ ion template methodology had been developed. In addition, demonstrate the RP-TLC purification of glycoconjugated chlorin derivatives to remove concomitant by-product, glycoconjugated porphyrin and bacteriochlorin derivatives. So now glycoconjugated porphyrin and chlorin derivatives can be produced in applicable scale and purity in photodynamic therapy.2.Estimation of Hydrophobicity of Glycoconjugated Porphyrin DerivativesHyrophobicity is fundamental characteristic for pharmakokinetics. We demonstrated the estimation of hydrophobicity of glycoconjugated porphyrin derivatives by means of reversed phase HPLC method. Significant sugedependent hydrophobicity was found clearly.3.Cellular Uptake of Glycoconjugated Porphyrin Derivatives by HeLa cellsPrior to in vitro photocytotoxicity test, the cellular uptake amount of glycoconjugated porphyrin derivatives by HeLa cells was determined by means of fluorometry. The uptake amount significantly depended on sugar unit attached, However, no apprent correlation between hydrophobicity and cellular uptake was found.4.In vitro Photocytotoxicity Test for Glycoconjugated Porphyrin DerivativesPreliminary in vitro photocytotoxicity test was performed for glycoconjugated porphyrin derivatives which exerted higher amount of cellular uptake. Even though the photocytotoxicity was not connected to the cellular uptake amount, photocytotoxicity highly depended on sugar unit attached. These results suggest the possibility of glyco-regulation of photocytotoxicity in PDT.
1.糖基卟啉衍生物的新合成策略为了提高糖基卟啉衍生物的产率,特别是间位取代的四苯基卟啉,开发了Zn2+离子模板法。此外,展示了糖缀合二氢卟酚衍生物的 RP-TLC 纯化,以去除伴随的副产物、糖缀合卟啉和菌绿素衍生物。因此,现在可以以适合光动力治疗的规模和纯度生产糖基卟啉和二氢卟酚衍生物。2.糖基卟啉衍生物的疏水性估计疏水性是药代动力学的基本特征。我们展示了通过反相 HPLC 方法评估糖缀合卟啉衍生物的疏水性。明显地发现了显着的糖依赖性疏水性。3.HeLa细胞对糖基卟啉衍生物的细胞摄取在体外光细胞毒性试验之前,采用荧光法测定HeLa细胞对糖基卟啉衍生物的细胞摄取量。摄取量明显取决于所附着的糖单元,但疏水性与细胞摄取之间没有发现明显的相关性。4.糖基卟啉衍生物的体外光细胞毒性试验对细胞摄取量较高的糖基卟啉衍生物进行了初步的体外光细胞毒性试验。尽管光细胞毒性与细胞摄取量无关,但光细胞毒性高度依赖于附着的糖单元。这些结果表明 PDT 中光细胞毒性的糖调节的可能性。
项目成果
期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hydrohobicity Parameters (Log P) og Glycoconjugated Porphyrins for Photodynamic Therapy Evaluated by Reversed Phase HPLC
通过反相 HPLC 评估用于光动力治疗的疏水性参数 (Log P) og 糖基卟啉
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:S.Hirohara
- 通讯作者:S.Hirohara
Hydrohobicity Parameters (Log P) of Glycoconjugated Porphyrins for Photodynamic Therapy Evaluated by Reversed Phase HPLC
通过反相 HPLC 评估用于光动力治疗的糖共轭卟啉的疏水性参数 (Log P)
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:S.Hirohara
- 通讯作者:S.Hirohara
Y.Mikata: "Unprecedented Sugar-Dependent In Vivo Antitumor Activity of Carbohydrate-Pendant cis-Diamminedichloroplatinum(II)Complexes"Bioorg. Med. Chem. Lett. 11. 3045-3047 (2001)
Y.Mikata:“碳水化合物悬垂顺式二氨二氯铂 (II) 复合物具有前所未有的糖依赖性体内抗肿瘤活性”Bioorg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Mikata: "Sugar-Pendant Diamines"J. Org. Chem. 66. 3783-3789 (2001)
Y.Mikata:“糖坠二胺”J。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Development of Novel Sugar Linked Photosensitizers for Photocynamic Therapy
用于光动力疗法的新型糖连接光敏剂的开发
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:S.Yano
- 通讯作者:S.Yano
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANO Shiganobu其他文献
YANO Shiganobu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Optical Surface Applicator Light Dosimetry for Ruthenium-based Photosensitizer Mediated Intraoperative Photodynamic Therapy
用于钌基光敏剂介导的术中光动力治疗的光学表面照射器光剂量测定
- 批准号:
10303270 - 财政年份:2021
- 资助金额:
$ 8.64万 - 项目类别:
Optical Surface Applicator Light Dosimetry for Ruthenium-based Photosensitizer Mediated Intraoperative Photodynamic Therapy
用于钌基光敏剂介导的术中光动力治疗的光学表面照射器光剂量测定
- 批准号:
10454364 - 财政年份:2021
- 资助金额:
$ 8.64万 - 项目类别:
Developments of triple pH-activatable photosensitizer for highly selective photodynamic therapy of cancer
用于癌症高选择性光动力治疗的三重pH激活光敏剂的开发
- 批准号:
19K05688 - 财政年份:2019
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel photodynamic therapy using next generation photosensitizer
使用下一代光敏剂开发新型光动力疗法
- 批准号:
18K15758 - 财政年份:2018
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of photodynamic therapy with a novel photosensitizer for gemcitabine resistant pancreatic cancer
新型光敏剂治疗吉西他滨耐药胰腺癌的光动力疗法的建立
- 批准号:
17H07008 - 财政年份:2017
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of cancer cell selective photodynamic therapy by sugar-conjugated photosensitizer
糖缀合光敏剂癌细胞选择性光动力疗法的进展
- 批准号:
17K09356 - 财政年份:2017
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of sono-activatable photosensitizer for photodynamic therapy of cancer
开发用于癌症光动力治疗的声激活光敏剂
- 批准号:
16K05741 - 财政年份:2016
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Evaluation of Fullerene-fluorescence dye hybrid Nanoparticles for the Photosensitizer in Photodynamic Therapy
光动力治疗中光敏剂富勒烯-荧光染料杂化纳米粒子的设计与评价
- 批准号:
25860034 - 财政年份:2013
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of traceable photosensitizer to produce enough effect of photodynamic therapy
开发可追踪光敏剂以产生足够的光动力治疗效果
- 批准号:
25460053 - 财政年份:2013
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next generation of photosensitizer for fluorescent imaging and photodynamic therapy of cancer
开发用于癌症荧光成像和光动力治疗的下一代光敏剂
- 批准号:
23790063 - 财政年份:2011
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




